A carregar...
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
Objective. SSc is an autoimmune disease characterized by fibrosis of the skin and internal organs. Although the aetiology remains uncertain, many reports have suggested that IL-6 is involved in SSc pathogenesis. Tocilizumab, an anti-IL-6 receptor antibody, is an anti-arthritis medicine that works th...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2981510/ https://ncbi.nlm.nih.gov/pubmed/20819796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keq275 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|